7:15 AM Welcome and Introduction

7:30-8:30 AM
New Trends in Managing the AF Epidemic Moderators: Nassir Marrouche, MD and Natalia Trayanova, PhD, MS
All lectures 7 minutes. Panel and Audience Discussion 25 minutes.

Advances in Achieving Sustainable Weight Loss and Implications for Health Outcomes
Donna Ryan, MD

Comparison of Consumer Wearable Smart Devices for AF Detection
Sana Al-Khatib, MD

Advances in Artificial Intelligence for the Prediction, Detection, and Treatment of Atrial Fibrillation
Shaan Khurshid, MD

Machine Learning for Prediction of Atrial Fibrillation Ablation Outcomes
Tina Baykaner, MD

Role of Technology in Addressing Inequities in AF Management
Kevin Thomas, MD

Panel and Audience Discussion (25 minutes) – All Faculty

8:30-9:30 AM
Spotlight Session I – New and Emerging Technologies in Arrhythmia Management
Moderator: Paul Wang, MD
All lectures 5 minutes. FDA Presentation 7 minutes.

IV Sotalol for Atrial Fibrillation – Insights from the PEAKS Registry (AltaThera Pharmaceuticals)
Jared Bunch, MD

A Novel PFA Platform – Using a Multipurpose Catheter and Coherent Sine Wave Burst (CSE) for AF Ablation – Initial Experience from the FIH Trial (Arga MedtechSteradian Shield)
Ante Anic, MD

Proactive Esophageal Cooling – Data Update and Overview (Attune Medical)
Dinesh Sharma, MD

3D Navigation & AI Enabled Mapping for Pulsed Field Ablation (CardioNXT)
Anil Rajendra, MD

Vascular Closure System – Early Ambulation, Workflow, Efficiencies, & Patient Satisfaction (Haemonetics)
Larry Chinitz, MD

Intranasal Etripamil in AF-RVR: Data on Efficacy for Acute Rate Control (Milestone Pharmaceuticals)
Jonathan Piccini, MD

First Clinical Experience Performing Ablations with SentiAR Holographic Guidance System (SentiAR)
Gregory Michaud, MD

Clinical Roadmap for Volta Medical’s AI Technology (Volta Medical)
Jose Osorio, MD

Multiflex Steerable Sheath to Facilitate Electrophysiology & Structural Heart Interventions (Vizaramed)
Devi Nair, MD

FDA Lecture: Effectiveness Evaluation for New Technologies in AF Ablation Device Trials
Jun Dong, MD, Medical Officer, Office of Cardiovascular Devices, CDRH, US FDA

9:30-10:00 AM Break

10 AM-12:30 PM
Case Transmissions Session 1
Moderator: Moussa Mansour, MD
Panel: Gerhard Hindricks, MD, Pierre Jais, MD, Andrea Natale, MD, Vivek Reddy, MD, Dhanunjaya Lakkireddy, MD

Ablation of PAF Using a Dual Energy Pulsed Field-Radiofrequency STSF Catheter
David Newton, MD (Savannah, GA)

PVI and Posterior Wall Ablation of Persistent AF Using FARAWAVE Pentaspline PFA Catheter
Moussa Mansour, MD (Boston, MA)

Pulmonary Vein Isolation Using SPHERE 360 Large Lattice Tip PFA Catheter
Petr Neuzil, MD, PhD and Vivek Reddy, MD (New York, NY)

Disc and Lobe LAA Closure using Amulet with ICE Guidance
Usman Siddiqui, MD (Orlando, FL)

LAA Closure with the Conformal Device
Christopher Ellis, MD (Nashville, TN)

12:30-1:30 PM Lunch

1:30-2:30 PM
Case Transmissions Session 2
Moderator: Moussa Mansour, MD
Panel: Luigi Di Biase, MD, PhD, Walid Saliba, MD, and Kenneth Ellenbogen, MD

WATCHMAN Left Atrial Appendage Closure with Single-Step Transseptal Access
Moussa Mansour, MD (Boston, MA)

PVI Using POLARx FIT Novel Expandable Cryoballoon with Single-Step Transseptal Access
Bradley Knight, MD (Northwestern Chicago)

2:30-3:30 PM
Stroke Risk Management in Atrial Fibrillation Session I
Moderators: Rod Passman, MD and Jonathan Piccini, MD
All lectures 7 minutes. Panel and Audience Discussion 25 minutes.

Anticoagulation in Patients with Implantable Device Detected Atrial High Rate Episodes NOAH-AFNET6 Trial/ARTESIA/other
Daniel Singer, MD

Factor XI/XIa Inhibitors – Mechanisms, Clinical Outcomes, and Future Directions
Elaine Hylek, MD

Outcome Severity with Falls on Anticoagulant Drugs vs LAA Closure Devices
Mingming Ning, MD, MSc

Stroke Severity with Different Stroke Prophylaxis Therapies: DOACs vs LAA Closure Devices
Mohit Turagam, MD

Single Antiplatelet Therapy with New Generation LAA Closure Devices
Walid Saliba, MD

Panel and Audience Discussion (25 minutes) – All Faculty

3:30-4:30 PM
Stroke Risk Management in Atrial Fibrillation Session II
Supported by an Educational Grant from Boston Scientific
Moderators: Walid Saliba, MD and
Devi Nair, MD
All lectures 7 minutes. Panel and Audience Discussion 25 minutes.

Safety and Efficacy of Watchman FLX: Real World Experience (SURPASS Registry)
James Freeman, MD

ICE Guided Left Atrial Appendage Closure
Shephal Doshi, MD

Peri-Device Leaks with LAA Closure Devices: What Does the Evidence Show?
Rodney Horton, MD

Concomitant Left Atrial Appendage Closure with Other Cardiac Procedures
Oussama Wazni, MD

New Devices for LAA Closure – Future Directions in Technology
Vivek Reddy, MD

Panel and Audience Discussion – All Faculty & Andrew Farb, MD, Chief Medical Officer, Office of Cardiovascular Devices, CDRH, US FDA

4:30 – 5:00 PM Break

5:00 – 6:00 PM
Improving Technologies and Workflows for Efficiency and Outcomes
Supported by an Educational Grant from Abbott
Moderators: Andrea Natale, MD and
John Day, MD
All lectures 7 minutes. Panel Discussion 25 minutes.

Long Term Outcomes of LAA Closure with a Disc and Lobe Occluder
DJ Lakkireddy, MD

Optimizing Efficacy and Safety of LAA Closure with a Disc and Lobe Occluder
Jacqueline Saw, MD

Advances in Localizing and Defining Arrhythmia Mechanisms – Impact of Omnipolar Peak Frequency Mapping
Jonathan Piccini, MD

Optimization of Radiofrequency Ablation with a Flexible Tip Contact Force Sensing Catheter
Larry Chinitz, MD

First in Human Experience with a Balloon-Based Pulsed Field Ablation System
Atul Verma, MD

Panel and Audience Discussion (25 minutes): All Faculty